As plant seed-derived procyanidins usually have elimination half-lives of 12h51,52, such a sustained improvement in physical function following a single course of PCC1 treatment circumvents the need for continuous treatment with the senolytic agent, further implying that the activity of PCC1 is sufficient to avert senescent cell-induced physical dysfunction.